Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Code: GDME0143EPD | Published: Jan-2016 | Pages: 216 | GlobalData
Price :
$4,000.00
USD

* Required Fields

$4,000.00

Details

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Summary

GlobalDatas Medical Devices sector report, "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Alzheimer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
AC Immune SA
Acobiom
Acumen Pharmaceuticals, Inc.
Adlyfe Inc.
Advanced Genomic Technology, LLC
ADx NeuroSciences NV
Akrivis Technologies, LLC
Alere Inc.
Alzhyme Pty Ltd
Amarantus Bioscience Holdings, Inc.
Applied Proteomics, Inc.
Araclon Biotech, S.L.
Banyan Biomarkers, Inc.
BioArctic Neuroscience AB
biOasis Technologies Inc.
Biomedical Development Corporation
BioSystems International
C2N Diagnostics LLC
Chronix Biomedical, Inc.
Cognoptix, Inc.
Columbia University
CompanDX Ltd.
Consejo Superior de Investigaciones Cientificas
Cymedx
DiaGenic ASA
DiamiR LLC
DiaPat GmbH
Diaxonhit S.A.
Dr. Grossegger & Drbal GmbH
DS Pharma Biomedical Co., Ltd.
Durin Technologies, Inc.
Emory University
Fianostics GmbH
Gene Solutions LLC
GeneNews Limited
Genentech, Inc.
Georg-August-Universitat Gottingen
Ghent University
HealthTell, Inc.
ICDD-sas
Innovative California Biosciences International, Inc.
Innovative Health Diagnostics
Institut National de la Sante et de la Recherche Medicale
Instituto de Estructura de la Materia
Integrated Diagnostics Inc.
Janssen Pharmaceutica N.V.
KineMed, Inc.
Laboratory Corporation of America Holdings
McGill University Health Center
Memory Dx, LLC
Meso Scale Diagnostics LLC
Myriad Genetics, Inc.
NanoSomiX, Inc.
Nanosphere, Inc.
Neuron Biopharma SA
NeuroQuest, Ltd.
Neurotrope Bioscience, Inc.
NeuroVision Imaging LLC.
Newcastle University
NextGen Sciences Dx Inc
Novel Bio-spectrum Technologies, Inc.
Oligomerix, inc.
OPKO Health, Inc.
Orasi Medical, Inc.
Oregon Health & Science University
Oryzon Genomics S.A.
Oxford Biodynamics Limited
PDx BioTech
PeriRx LLC
Pre Diagnostics AS
Predemtec GmbH
ProMIS Neurosciences Inc.
Proplex Technologies, Llc
Protagen AG
Proteome Sciences Plc
Proteomics International Pty Ltd
Quanterix Corporation
Redox Diagnostics LLC
Saladax Biomedical, Inc.
Satoris, Inc.
Scout Diagnostics, LLC
Singulex, Inc.
SomaLogic, Inc.
Takeda Pharmaceuticals International AG
The Johns Hopkins University
The University of Melbourne
Trinity College Dublin
True Diagnostics, Inc.
University of California, Irvine
University of Chicago
University of Georgia
University of Luxembourg
University of Nottingham
University of South Florida
University of Texas Health Science Center at Houston
University of Texas Southwestern Medical Center at Dallas
US Biomarkers, Inc.
Vermillion, Inc.
Vitruvian Biomedical, Inc.
Washington University in St. Louis
XRGenomics LTD
Zoiray Technologies Inc.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Medical Devices
GlobalData

Our Clients